Market closedRefreshes 15sData NSENot investment advice
Neogen Chemicals

Neogen Chemicals

NSE: NEOGENBSE 542665Basic Materialswww.neogenchem.com
View MapTV Chart
2,064.40
30.70+1.51%
DAY1,993
₹2,064.40
2,083
52W967
₹2,064.40
2,087
Open2,080.00
Prev Close2,033.70
Bid2,064.30100
Ask2,064.50100
Volume111.9K24%vs 20D avg
Market Cap₹5,434.62 Cr
Promoter Hold.51.2%
Face Value₹10
Fwd P/E39.66
PEG
EV/EBITDA46.99
P/S6.49
ROA2.95%
Beta0.62
Div Payout9.17%
Valuation

Neogen Chemicals Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Neogen Chemicals Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Neogen Chemicals Ltd trades at a P/E of 186.16× and P/B of 6.60×.

Key MetricsLive · as of 15 Jun 2026
the price tag

Valuation

Market Cap
₹5,434.62 Cr
P/E Ratio
watch186.16
P/B Ratio
watch6.6
EPS
10.98
the engine

Profitability

ROE
watch3.58%
ROCE
watch8.82%
Net Margin
watch3.33%
Op Margin
avg12.73%
the trajectory

Growth

EPS YoY
good375.9%
Revenue YoY
good21.6%
Qtr Sales
avg3.77%
Qtr Profit
watch-10.6%
the balance sheet

Financial Health

Debt / Equity
watch170.92
Book Value
309.59
Div Yield
avg0.05%
Promoter Hold.
good51.2%
Financials

Neogen Chemicals Ltd financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Neogen Chemicals Ltd, switchable between annual and quarterly views, consolidated or standalone.

Neogen Chemicals Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹5,434.62 Cr and reported EPS of ₹10.98.

Period20192020202120222023202420252026
Revenue from Operations
239
306
336
487
686
691
778
862
Other Income
1
0
0
1
4
7
4
6
Total Income
240
306
337
488
691
698
782
868
Cost of Goods Sold (COGS)
141
184
198
275
389
382
423
466
Gross Profit
98
122
139
212
298
308
355
396
+Operating Expenses
55
64
74
126
186
198
218
258
EBITDA
43
58
64
87
112
110
136
138
+Non-Operating Expenses
15
17
21
31
45
65
62
103
Profit Before Tax (PBT)
29
41
44
57
71
53
50
41
+Tax Expense
8
12
13
12
21
17
15
12
Profit After Tax (PAT)
21
29
31
45
50
36
35
29
Earnings Per Share (EPS)
8.98
12.28
13.43
17.90
20.04
13.51
13.20
10.90
Diluted Shares Outstanding (Nos.)
2
2
2
2
2
3
3
3
+Additional Disclosures
351
449
491
706
1,009
1,028
1,140
1,294
Sales Growth %
28.05
9.90
44.84
40.83
0.65
12.58
10.85
YoY Sales Growth %
28.05
9.90
44.84
40.83
0.65
12.58
10.85
Material Cost %
67
74
54
71
71
69
65
74
Employee Cost %
5
6
6
6
7
9
8
10
Other Cost %
18
15
16
19
20
20
20
19
OPM %
18
19
19
18
16
16
18
16
Tax %
28
30
29
22
30
33
31
30
Profit Growth %
36.80
9.34
42.44
11.97
-28.66
-2.30
-17.46
Gross Margin %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA Margin %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Coverage Ratio
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Additional Fields
41
53
57
75
95
87
109
110
all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Neogen Chemicals segment analysis: revenue and profit mix.

Disclosed business segments at Neogen Chemicals with their share of revenue and profit, switchable between consolidated and standalone reporting.

Neogen Chemicals discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Investment Thesis

Neogen Chemicals Ltd investment thesis: bull case, bear case, and the flip lines.

Why someone would buy Neogen Chemicals Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.

Neogen Chemicals Ltd's investment case rests on 7 positive markers and 11 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • Neogen Chemicals maintains a strong promoter holding of 51.2%, signaling high confidence in its future and reducing external shareholding risks. This ownership level suggests a long-term commitment to the company's success.

  • The company exhibits a healthy operating profit margin (OPM) of 17.5%, indicating efficient cost management and strong pricing power in the specialty chemicals industry. This profitability is a key financial health indicator.

  • Neogen Chemicals holds a substantial market capitalization of ₹3842 crore, signifying its considerable size and influence within the specialty chemicals sector. This large cap can attract investor interest and provide stability.

  • Operating in the growing specialty chemicals sector, Neogen benefits from a resilient market known for high margins. This strong industry positioning offers potential for sustained long-term growth and profitability.

  • The specialty chemicals sector, where Neogen operates, is experiencing robust growth driven by increasing demand across various end-user industries. This trend presents significant expansion opportunities for the company.

bear case

What can break it.

  • Neogen Chemicals has a high P/E ratio of 95.00, suggesting the stock may be overvalued relative to its earnings. Investors should carefully assess this valuation and the potential risks associated with such a high multiple.

  • The company's debt-to-equity ratio of 0.76 indicates a notable level of debt, which could elevate financial risk, particularly during economic downturns. This substantial debt requires close monitoring by investors.

  • Quarterly profit variability is a concern, with a recent -10.60% change in PAT. This volatility highlights the need for careful analysis of future earnings and potential impacts of market fluctuations on profitability.

  • A notable decrease in promoter holding from 60.19% to 51.22% warrants attention. Investors should monitor further changes, as this could signal shifts in company strategy or confidence, despite the current strong level.

  • The company exhibits low returns on equity (ROE) at 5.59% and capital employed (ROCE) at 8.82%. These figures are significantly lower than industry peers, indicating suboptimal capital efficiency and profitability.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 242. The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 171.42. Balance sheet risk re-prices growth multiples fast.

  • Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.

Shareholding

Neogen shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Neogen — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Neogen Chemicals Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Neogen Chemicals Ltd is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
Pidilite Industries Ltd
₹1.60 Lakh Cr
Best Profit Growth
Valiant Organics Ltd
1423.00 %
Highest Dividend Yield
Chemcon Speciality Chemicals Ltd
6.67 %
Technicals

Neogen Chemicals Ltd technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Neogen Chemicals Ltd — derived from the live tape, not yesterday's close.

Neogen Chemicals Ltd last traded at ₹2,064.4 with an intraday range of ₹1,993–₹2,083.4 — live indicator, pivot and CPR signals below.

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹2064.40
LevelPrice (₹)Distance% Δ
R42281.67+217.27+10.52%
R32191.27+126.87+6.15%
R22137.33+72.93+3.53%
R12100.87+36.47+1.77%
PIVOT2046.93-17.47-0.85%
CURRENT2064.40
S11829.67-234.73-11.37%
S21920.07-144.33-6.99%
S31956.53-107.87-5.23%
S42010.47-53.93-2.61%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 2038.20P: 2046.93TC: 2055.67
R1
R2
R3
R4
indicator
LTP: 2064.40
PDH: 2087.30
PDL: 1928.00
● Market Sentiment

NEOGEN is trading Above CPR, indicating Bullishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: 2033 ~ 2083.4

● Price Position

Trading Inside opening range

Delivery & Volume

Neogen Chemicals Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Neogen Chemicals Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Neogen Chemicals Ltd stood at 33.6% of traded volume, against a 20-day average of 44.4%.

Avg Delivery (20D)44.4%-10.8 ppt latest vs avg
Highest Delivery72.7%on 02 Jun
Avg Volume (20D)1.48 L20-day run-rate
Conviction Trend↑ Strengthening-10.8 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Neogen Chemicals announcements: results, concalls, ratings, M&A.

Filings Neogen Chemicals sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Neogen Chemicals files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 222 documents below.

  1. 12 Jun 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Neogen Chemicals Limited has informed the Exchange about Schedule of meet

  2. 25 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Neogen Chemicals Limited has informed the Exchange about Transcript

  3. 12 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Neogen Chemicals Limited has informed the Exchange about Schedule of meet

  4. 28 Apr 2026General UpdatesView PDF

    General Updates

    Neogen Chemicals Limited has informed the Exchange about disclosure pursuant to regulation 30(9) read with Schedule III of the SEBI (Listing…

  5. 28 Apr 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    Neogen Chemicals Limited has informed the Exchange about Intimation to the Shareholders regarding Second 100 days Campaign Saksham Niveshak -…

Insider Activity

Neogen Chemicals insider trading: promoter and management activity.

Promoter, director and designated-employee transactions in Neogen Chemicals as reported to SEBI — buying and selling signals from the people who know the business best.

Neogen Chemicals insider activity below tracks 14 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).

InsiderCategoryTxn DateActionQuantityValue (₹)Price
CADAMBA SOLUTIONS PRIVATE LIMITEDInsider18 Apr 2026buy+10.00 L₹161 Cr₹1,610.00
CADAMBA SOLUTIONS PRIVATE LIMITEDInsider18 Apr 2026buy+10.00 L₹161 Cr₹1,610.00
CADAMBA SOLUTIONS PRIVATE LIMITEDInsider18 Apr 2026buy+10.00 L₹161 Cr₹1,610.00
CADAMBA SOLUTIONS PRIVATE LIMITEDInsider18 Apr 2026buy+10.00 L₹161 Cr₹1,610.00
HARIN HARIDAS KANANIInsider30 Mar 2026buy+13.19 L
HARIN HARIDAS KANANIInsider30 Mar 2026buy+13.19 L
HARIN HARIDAS KANANIInsider30 Mar 2026buy+13.19 L
HARIN HARIDAS KANANIInsider30 Mar 2026buy+13.19 L
HARIDAS THAKARSHI KANANIInsider11 Apr 2025sell29.13 L
BEENA HARIDAS KANANIInsider11 Apr 2025buy+29.13 L
Corporate Actions

Neogen Chemicals dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Neogen Chemicals has declared, sequenced by announce and record date.

Neogen Chemicals corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Neogen Chemicals Ltd: business, sector, key facts.

What Neogen Chemicals Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Neogen Chemicals Ltd operates in the Basic Materials, listed as NSE: NEOGEN, BSE: 542665.

NEOGEN
Basic Materials

Neogen Chemicals Ltd

NSE · NEOGEN·BSE · 542665·www.neogenchem.com

Neogen Chemicals Limited is an Indian specialty chemical manufacturer and supplier, established in 1989 and headquartered in Thane. Their primary business revolves around the production and sale of a diverse range of chemical compounds, catering to a broad spectrum of industrial sectors.

A significant portion of Neogen's product portfolio centers on organobromine compounds. This encompasses a wide variety of alkyl bromides, dibromoalkanes, and other bromine-based derivatives. They also offer specialty chloro compounds, organolithium compounds, and inorganic chemicals such as bromine compounds and lithium salts. The company's expertise extends to Grignard reagents and advanced intermediates, highlighting their proficiency in complex chemical synthesis.

Beyond the specific chemical compounds, Neogen provides a comprehensive suite of chemical services. This includes custom synthesis tailored to client-specific needs, along with contract manufacturing services for larger-scale production requirements. Their expertise covers various chemical reactions such as alkylation, acylation, and halogenation, showcasing their versatile capabilities in chemical transformation.

The company's diverse clientele spans a wide array of industries. Key sectors served include pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, and specialty polymers. Their global reach is demonstrated by exports to 31 countries, solidifying their position as a significant player in the international specialty chemicals market.

company facts
Founded / IPO
Employees
SectorBasic Materials
HeadquartersThane, India
Market Cap₹5,434.62 Cr
Listed OnNSE
leadership18 on record
B. P. Pant
Senior Vice President of Business Development
Dr. Harin Haridas Kanani Ph.D.
MD & Executive Director
Dr. Harin Kanani
Managing Director, Executive Director
Mr. Anurag Surana
Non-Executive Chairman of the Board
Mr. Gopikrishnan Sarathy
Chief Financial Officer
Mr. Gopikrishnan Sarathy
Chief Financial Officer
Mr. Haridas Kanani
Chairman Emeritus
Mr. Kirit Chauhan
Senior Vice President of Human Resource
Mr. Manoj Pati
Non-Executive Independent Director
Mr. Rajeshkumar Shah
Non-Executive Independent Director
Mrs. Avi Sabavala
Non-Executive Independent Woman Director
Mr. Shyamsunder Radeshyam Upadhyay
Director of Operations & Whole Time Director
§ ∞ · Plainly Answered

Questions investors ask about Neogen Chemicals Ltd (NEOGEN).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Neogen Chemicals Ltd (NEOGEN)?

The current share price of Neogen Chemicals Ltd (NEOGEN) is ₹2,064.4. Today, the stock has gained by ₹30.70 (1.51%), trading in a range of ₹1,993 to ₹2,083.4. The stock opened at ₹2,080 with a trading volume of 1,11,918 shares.

02Is Neogen Chemicals Ltd stock a good investment for long-term?

Neogen Chemicals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹5,434.62 crores, P/E ratio of 186.16, ROE of 3.58%, and ROCE of 8.82%. The dividend yield stands at 0.05%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Neogen Chemicals Ltd stock?

The 52-week high price of Neogen Chemicals Ltd (NEOGEN) is ₹2,087.3, while the 52-week low is ₹966.7. Currently trading at ₹2,064.4, the stock is 98.0% away from its 52-week low and 1.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Neogen Chemicals Ltd stock at the current price?

Whether to buy Neogen Chemicals Ltd stock at ₹2,064.4 depends on multiple factors. The stock is currently trading with a P/E ratio of 186.16 and P/B ratio of 6.60. Today's performance shows a gain of 1.51%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Neogen Chemicals Ltd and when is the next dividend?

Neogen Chemicals Ltd offers a dividend yield of 0.05%, which means for every ₹100 invested at the current price of ₹2,064.4, you can expect to receive approximately ₹0.05 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Neogen Chemicals Ltd?

Neogen Chemicals Ltd's key financial metrics include: P/E Ratio: 186.16, P/B Ratio: 6.60, ROE: 3.58%, ROCE: 8.82%, Dividend Yield: 0.05%, EPS: ₹10.98, Book Value: ₹309.59, and Debt-to-Equity: 170.92. The company's market cap stands at ₹5,434.62 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Neogen Chemicals Ltd stock performing today in the market?

Neogen Chemicals Ltd stock opened at ₹2,080 and is currently trading at ₹2,064.4, showing a gain of ₹30.70 (1.51%). The intraday high is ₹2,083.4 and low is ₹1,993. The trading volume stands at 1,11,918 shares, indicating moderate market participation today.

08What is the P/E ratio of Neogen Chemicals Ltd and what does it indicate?

Neogen Chemicals Ltd has a Price-to-Earnings (P/E) ratio of 186.16, which means investors are willing to pay ₹186.16 for every ₹1 of earnings. With an EPS of ₹10.98, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Neogen Chemicals Ltd (NEOGEN) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.